At the beginning of December, 90 board members and executives from the biotechnology sector gathered in Reutlingen for the 17th CEO & CFO Meeting of BIO Deutschland. The choice of Reutlingen as the location of the meeting was made in conjunction with BioRegio STERN.
BIO Deutschland’s board convened for last time in 2015 after the CEO & CFO Meeting. The board members reviewed the past year’s activities and expressed their strong satisaction with the association’s achievements in 2015.
The autumn meeting of EUCOPE’s Market Access Working Group took up recent biopharma developments at the European level, focusing on topics related to approval and market entry.